Top Markets
Coin of the day
Algernon Pharmaceuticals Inc. Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

AGN
Clasificación en acciones #38375
Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company... Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company dedicated to discovering and developing new treatments. Their research and development efforts concentrate on a range of serious conditions, including non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19, operating across Canada and Australia. The company's primary drug candidate, NP-120, acts as an N-methyl-d-aspartate (NMDA) receptor glutamate antagonist. This compound specifically targets the NMDA-type subunit 2B (Glu2NB) and also demonstrates agonist activity for the Sigma-1 receptor, a chaperone protein elevated during endoplasmic reticulum stress. Furthermore, Algernon is advancing AP-188, a psychedelic agent from the tryptamine family, for treating ischemic stroke in humans. Preclinical investigations for AP-188, as part of their stroke clinical research program, are underway through a collaboration with Charles River Laboratories. Established in 2015, Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
Precio por acción
$0.29357476
Última sincronización: 2026-05-14
Capitalización bursátil
$1.02M
Cambio (1 día)
1.27%
Cambio (1 año)
-42.07%
País
CA
Comercio Algernon Pharmaceuticals Inc. (AGN)

Categoría

Historial del precio de la acción de Algernon Pharmaceuticals Inc. (AGN)
Precio más alto de cierre: $0.29 el 2026-05-01

Precio más bajo de cierre: $169.74 el 2016-02-01
Historial del precio de la acción de Algernon Pharmaceuticals Inc. desde 2016 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -22.61%
2025 16.84%
2024 -12.82%
2023 -88.01%
2022 -47.29%
2021 -85.85%
2020 524.96%
2019 -58.71%
2018 -64.50%
2017 5.94%
2016 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE